Mealey's (March 8, 2018, 2:03 PM EST) -- OAKLAND, Calif. — A California federal judge on March 5 denied a drug-coding database’s motion to stay a case pending its appeal of a decision denying its motion to strike a pharmaceutical company’s claims for violation of California unfair competition law (UCL) and other state law claims, finding that no substantive overlap on the merits of the state and federal law claims existed, requiring a divestiture of jurisdiction (Exeltis USA Inc. v. First Databank Inc., No. 17-cv-04810, N.D. Calif., 2018 U.S. Dist. LEXIS 35737)....